Active immunisation against gastric inhibitory polypeptide (GIP) improves blood glucose control in an animal model of obesity-diabetes (Q38359890)

2 September 2017

Active immunisation against gastric inhibitory polypeptide (GIP) improves blood glucose control in an animal model of obesity-diabetes (English)

1 reference

2 September 2017

0 references

0 references

0 references

1 reference

Nigel Irwin

1

1 reference

2 September 2017

Paula L McClean

2

1 reference

2 September 2017

Steven Patterson

3

1 reference

2 September 2017

Kerry Hunter

4

1 reference

2 September 2017

Peter R Flatt

5

1 reference

2 September 2017

1 January 2009

1 reference

2 September 2017

1 reference

2 September 2017

390

1 reference

2 September 2017

1

1 reference

2 September 2017

75-80

1 reference

Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet

2 September 2017

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.002

Plasma immunoreactive gastric inhibitory polypeptide in obese hyperglycaemic (ob/ob) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.002

Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.002

Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.002

Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.002

Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.002

Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.002

Activation of lipoprotein lipase by glucose-dependent insulinotropic polypeptide in adipocytes. A role for a protein kinase B, LKB1, and AMP-activated protein kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.002

ABC of obesity. Management: part II--drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.002

Inhibition of gastric inhibitory polypeptide signaling prevents obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.002

Changes in health behaviors among older Americans, 1990 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.002

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.002

Improved stability, insulin-releasing activity and antidiabetic potential of two novel N-terminal analogues of gastric inhibitory polypeptide: N-acetyl-GIP and pGlu-GIP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.002

Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.002

Extrapancreatic effects of GIP and GLP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.002

Functional GIP receptors are present on adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.002

GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.002

21 January 2018

Identifiers

DOI

10.1515/BC.2009.002

1 reference

2 September 2017

1 reference